Company Insight – Page 9 – media

Verge Genomics Raised $32 Million for Clinical Trial Work of AI Based Neuroscience Drugs

San Francisco based Verge Genomics, the Neuroscience based drug discovery company launched in 2015, has raised $32 million in early venture capital financing to bring its AI-generated compounds against Parkinson’s disease and amyotrophic lateral sclerosis (ALS) to clinics within the next three years.
- Source: FierceBiotech
- 680
- July 18, 2018
AI Company Insight digital health
Care Quality Commission Rates Digital GP Centre in Birmingham ‘Outstanding’

The CQC rated the South Doc Services Limited as ‘outstanding’ in a report on 11 July. The service operates virtual primary care services for the MyHealthcare GP federation, functioning at several hubs across Birmingham with more than 47 GP practices under its umbrella catering to around 300,000 registered patients. The report praised how the “service used technology to improve treatment and to support patients’ independence”.
- Source: DigitalHealth
- 679
- July 18, 2018
Company Insight digital health
Medtech Startup HeartHero Raises $2m in Seed Funding for its AED

$1.5 million was raised in a seed investment round to support the development of its futuristic automated external defibrillators by Hearthero, a medtech startup.
- Source: MassDevice
- 801
- July 17, 2018
Company Insight medtech seed funding
Biontech and Genevant Sciences Join Hands to Roll Out Rare Disease Drugs

In a joint venture, German biopharmaceutical firm BioNTech and Genevant Sciences, a genetic disorder therapeutics maker plan to develop mRNA therapy programmes targeting rare diseases with severely deficient medical attention.
- Source: Pharmaceutical Technology
- 755
- July 16, 2018
biotech Company Insight rare diseases
Novartis Shuts Down Its Antimicrobial Research

Despite the looming crises, Novartis will be shutting down antimicrobial research at its Novartis Institutes for Biomedical Research campus in Emeryville, California. There will be a loss of 140 jobs and the current projects will be put up for sale. This company was working on phase 2 clinical trial of LYS228 against complicated urinary tract infections and complicated intra-abdominal infections. The work on anti-dengue drugs and anti-malaria drugs (KAF156 and KAE609) were already in pipeline.
- Source: Fierce Biotech
- 742
- July 16, 2018
AMR antibiotic resistance Company Insight
mHealth Wearable Effective in Detecting AFib, STSI Study Finds

iBeat, a San Francisco-based start-up, launched a new pulse sensitive feature called iBeat Heart Watch which alerts healthcare professionals if it detects someone going into cardiac arrest.
- Source: MobiHealthNews
- 792
- July 13, 2018
atrial fibrillation Company Insight mHealth
New iBeat’s Watch Detects Cardiac Arrests and Alerts Services

iBeat, a San Francisco-based start-up, launched a new pulse sensitive feature called iBeat Heart Watch which alerts healthcare professionals if it detects someone going into cardiac arrest.
- Source: MobiHealthNews
- 645
- July 13, 2018
Company Insight heart attacks
NHS IT Systems Experience Downtime of About 1300 Hours in the Last Three Years

The FoI request was sent by enterprise IT firm Intercity Technology to as many as 143 NHS trusts in England. Out of these, 80 responded, of which 25 reported outages across their IT systems during the period from January 2015 to February 2018.
- Source: DigitalHealth.net
- 709
- July 12, 2018
Company Insight cybersecurity NHS
Fitbit Charge HR – Assessment of Health Conditions in Cancer Patients

A study report published in Nature's Digital Medicine partner journal shows that the wearable monitor Fitbit Charge HR could assess the health condition of cancer patients and predict their adverse events.
- Source: MobiHealthNews
- 690
- July 12, 2018
cancer Company Insight mHealth wearables
Cerner & Lumeris Collaborate for Value-Based Care Solution

Cerner and Lumeris have brought together their technologies to result in EHR agnostic. The Kansas City, Missouri-based Cerner specializes in EHRs and other IT solutions whereas the St. Louis, Missouri-based Lumeris’ technique involves value-based care.
- Source: MedCityNews
- 827
- July 11, 2018
Company Insight EHR

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.